Experts Matter. Find Yours.Connect for media, speaking, professional opportunities & more.Select a tabExpertise for "drug resistance“FiltersFiltersTop TopicsCompaniesCountriesMediaTop TopicsLife SciencesAlzheimer's DiseaseBiopharmaceuticalsBiotechnologyBioterrorismBird FluBusiness Development & PartnershipsCOVID-19 (Omicron, XBB, etc.)CancerClinical TrialsCommercializationCompanion DiagnosticsDisaster PreparednessDrug DesignDrug DevelopmentDrug Resistance / SuperbugsEpidemiologyGut HealthHealth DisparitiesHealth InnovationHealth TechnologiesInfectious DiseaseInfectious DiseasesLong COVIDMarketing & Corporate StrategyMedical GeneticsMedical Guideline and PolicyMedicinal ChemistryMicrobiome Molecular BiologyMolecular Cell BiologyMolecular DiagnosticsMonkeypoxNanomedicineNeurological Disorders (Multiple Sclerosis, Pain Management)OncologyOncology and Cancer ResearchOne HealthParkinson's DiseasePharmaceutical IndustryPolicy AnalysisPost-Pandemic Mental Health TrendsProgram ImplementationProject and Program ManagementPsychedelic MedicinePublic & Global HealthScientific Due DilligenceSubstance Use DisordersTechnology TransferTuberculosisShow All +CompaniesMaRS InnovationTexas Christian UniversityUniversity of ConnecticutUniversity of Toronto, Faculty of MedicineX-Biotix TherapeuticsCountriesUnited StatesCanadaMediaPodchaserPhotosVideoPublicationsDocuments/SlidesPreviousNextShowing 10 to 5 of 5 Results
